Abstract

Objective:

To investigate the association of T allele of the C825T polymorphism of the gene encoding the β3-subunit of G proteins (GNB3) with blood pressure response to diuretic therapy.

Methods:

Polymerase chain reaction combined with restriction enzyme digestion was used to detect the polymorphism of G protein of b3 subunit gene in 147 normotensive controls and 321hypertensive patients.48 hypertensive patients underwent monotherapy with hydrochlorothiazide for 4 weeks.

Results:

Mean declines in systolic and diastolic blood pressures were significantly greater in CT heterozygotes and TT homozygous (22.67±13.74mmHg,12.00±9.39mmHg) than in CC homozygotes(8.81±6.23 mmHg, 6.50±5.32 mmHg).In multiple regression models, the TT genotype remained a significant predictor of greater declines in systolic and diastolic blood pressures,(p<0.05). There were no significant difference of the GNB3 gene C825T polymorphism genotypes and alleles between hypertensive patients (CC:28.7%,CT:52%,TT:19.3% and C:50.7%,T:49.3%) and normotensive controls (CC:27.2%,CT:46.9%,TT:25.9% and C:50.7%,T:49.3%).

Conclusions:

The C825T polymorphism of GNB3 may help identify patients with essential hypertension who are more responsive to hydrochlorothiazide therapy,but the C825T polymorphism of GNB3 is not associated with essential hypertension.